News and features

EpiStem, one of the UK's leading stem cell research companies based in the Manchester science incubator, moves into 2006 with a much strengthened balance sheet following a private equity placing of GBP1.72 and the recognition by its peers of the leading edge technology platform for extracting and using adult epithelial stem cells for diagnostic and therapeutic purposes.

22/12/2005

EpiStem, one of the country’s leading adult stem cell companies, was recognised as the Biotechnology Company of the Year at the recent Northwest Biotechnology Awards organised by the Northwest Regional Development Agency (NWDA).

22/11/2005

EpiStem, the Manchester based epithelial tissue and adult stem cell specialist company, which provides expert advice and analysis to the biotechnology and pharmaceutical industries, announces that it has raised £1.72 million through a Private Placing by Zeus Capital to invest in its Novel Therapies Division and secure and promote its Intellectual Property over key genes which regulate adult epithelial stem cells.

24/10/2005